54 related articles for article (PubMed ID: 38619033)
1. Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy.
Fréour T; Barrière P; Masson D
Eur J Cancer; 2017 Mar; 74():1-8. PubMed ID: 28135602
[TBL] [Abstract][Full Text] [Related]
2. Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women.
Dunlop CE; Anderson RA
Maturitas; 2015 Mar; 80(3):245-50. PubMed ID: 25596814
[TBL] [Abstract][Full Text] [Related]
3. A New Model Including AMH Cut-off Levels to Predict Post-treatment Ovarian Function in Early Breast Cancer: A Prospective Cohort Study.
Omranipour R; Ahmadi-Harchegani F; Saberi A; Moini A; Shiri M; Jalaeefar A; Arian A; Seifollahi A; Madani M; Eslami B; Alipour S
Arch Iran Med; 2024 Feb; 27(2):96-104. PubMed ID: 38619033
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
[TBL] [Abstract][Full Text] [Related]
6. Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram.
Barnabei A; Strigari L; Marchetti P; Sini V; De Vecchis L; Corsello SM; Torino F
Oncologist; 2015 Oct; 20(10):1111-8. PubMed ID: 26341758
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer.
Anderson RA; Cameron DA
J Clin Endocrinol Metab; 2011 May; 96(5):1336-43. PubMed ID: 21325458
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
Dezellus A; Barriere P; Campone M; Lemanski C; Vanlemmens L; Mignot L; Delozier T; Levy C; Bendavid C; Debled M; Bachelot T; Jouannaud C; Loustalot C; Mouret-Reynier MA; Gallais-Umbert A; Masson D; Freour T
Eur J Cancer; 2017 Jul; 79():72-80. PubMed ID: 28463758
[TBL] [Abstract][Full Text] [Related]
9. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.
Zhou B; Kwan B; Desai MJ; Nalawade V; Ruddy KJ; Nathan PC; Henk HJ; Murphy JD; Whitcomb BW; Su HI
Fertil Steril; 2022 May; 117(5):1047-1056. PubMed ID: 35216831
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer.
Anderson RA; Kelsey TW; Perdrix A; Olympios N; Duhamel O; Lambertini M; Clatot F
Breast Cancer Res Treat; 2022 Apr; 192(2):273-282. PubMed ID: 34997365
[TBL] [Abstract][Full Text] [Related]
12. The Value of Anti-Müllerian Hormone in the Prediction of Spontaneous Pregnancy: A Systematic Review and Meta-Analysis.
Lin C; Jing M; Zhu W; Tu X; Chen Q; Wang X; Zheng Y; Zhang R
Front Endocrinol (Lausanne); 2021; 12():695157. PubMed ID: 34721287
[TBL] [Abstract][Full Text] [Related]
13. Fertility Counseling and Preservation for Breast Cancer Patients.
Dinas KD
Adv Exp Med Biol; 2020; 1252():181-187. PubMed ID: 32816280
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy in Breast Cancer Survivors.
Bjelic-Radisic V; Esfandbod M; Alipour S
Adv Exp Med Biol; 2020; 1252():165-174. PubMed ID: 32816278
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Survival Among Young Women With Stage I-III Breast Cancer: SEER 2000-2015.
Thomas A; Rhoads A; Pinkerton E; Schroeder MC; Conway KM; Hundley WG; McNally LR; Oleson J; Lynch CF; Romitti PA
JNCI Cancer Spectr; 2019 Sep; 3(3):pkz040. PubMed ID: 31392297
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]